Showing results (161-170 of 447) with videos related to
Sort By:
Pageof 45
Cancer|September 9, 2010
Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer: National Cancer Institute of Canada Clinical Trials Group Study PA.3Gilda da Cunha Santos, Neesha Dhani, Dongsheng Tu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 18, 2012
Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinomaNaoki Yanagawa, Charles Leduc, Derek Kohler, et al.Acta Cytologica|June 30, 2020
Implementation of PD-L1 22C3 IHC pharmDxTM in Cell Block Preparations of Lung Cancer: Concordance with Surgical Resections and Technical Validation of CytoLyt® PrefixationSi Kei Lou, Hyang Mi Ko, Tomonari Kinoshita, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2017
Synergy of WEE1 and mTOR Inhibition in Mutant <i>KRAS</i>-Driven Lung CancersJosephine Hai, Shengwu Liu, Lauren Bufe, et al.Investigational New Drugs|September 12, 2019
A phase Ib study of a PI3Kinase inhibitor BKM120 in combination with panitumumab in patients with KRAS wild-type advanced colorectal cancerRachel Goodwin, Derek Jonker, Eric Chen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2010
The ability to form primary tumor xenografts is predictive of increased risk of disease recurrence in early-stage non-small cell lung cancerThomas John, Derek Kohler, Melania Pintilie, et al.Cancer Research|May 31, 2019
Integrative Pharmacogenomics Analysis of Patient-Derived XenograftsArvind S Mer, Wail Ba-Alawi, Petr Smirnov, et al.Therapeutic Advances in Medical Oncology|November 22, 2021
The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancerBarbara Melosky, Parneet Cheema, Rosalyn A Juergens, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Skp2 gene copy number aberrations are common in non-small cell lung carcinoma, and its overexpression in tumors with ras mutation is a poor prognostic markerChang Qi Zhu, Fiona H Blackhall, Melania Pintilie, et al.Plos One|January 28, 2014
p120RasGAP is a mediator of rho pathway activation and tumorigenicity in the DLD1 colorectal cancer cell lineShawna L Organ, Josephine Hai, Nikolina Radulovich, et al.Pageof 45